AR090473A1 - Material no-viable derivado de probioticos apto para la prevencion y tratamiento de infeccion, composicion - Google Patents

Material no-viable derivado de probioticos apto para la prevencion y tratamiento de infeccion, composicion

Info

Publication number
AR090473A1
AR090473A1 ARP130100945A ARP130100945A AR090473A1 AR 090473 A1 AR090473 A1 AR 090473A1 AR P130100945 A ARP130100945 A AR P130100945A AR P130100945 A ARP130100945 A AR P130100945A AR 090473 A1 AR090473 A1 AR 090473A1
Authority
AR
Argentina
Prior art keywords
composition
culture
prevention
treatment
phase
Prior art date
Application number
ARP130100945A
Other languages
English (en)
Inventor
K Poels Eduard
Gross Gabriele
M Overkamp Karin
Braaksma Machtelt
A F Van Tol Eric
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48045112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR090473(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of AR090473A1 publication Critical patent/AR090473A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Una composición que comprende un sobrenadante del cultivo a partir de una fase de crecimiento exponencial tardía de un proceso de cultivo por lotes para un probiótico tal como el LGG, para uso en el tratamiento o prevención de la infección por un agente patógeno tal como el C. sakazakii. Reivindicación 4: Una composición para el uso en el tratamiento o prevención de una infección patógena de acuerdo con la reivindicación 1, obtenida por un proceso caracterizado porque comprende los pasos de: (a) someter un probiótico a cultivo en un medio de cultivo adecuado utilizando un proceso por lotes; (b) recolectar el sobrenadante del cultivo en la fase de crecimiento exponencial tardía del paso de cultivo, cuya fase es definida con referencia a la segunda mitad del tiempo entre la fase de latencia y la fase estacionaria del proceso de cultivo por lotes; (c) remover opcionalmente los componentes de bajo peso molecular a partir del sobrenadante a fin de retener los componentes de peso molecular encima de 5 kDa; y (d) remover contenidos líquidos a partir del sobrenadante del cultivo a fin de obtener la composición. Reivindicación 7: La composición de la reivindicación 1, caracterizada porque el cultivo por lotes es llevado a cabo en un medio de cultivo desprovisto de polisorbatos. Reivindicación 10: La composición de la reivindicación 1, caracterizada porque comprende una fórmula o composición nutricional o suplemento, un alimento medicinal, o un alimento para propósitos medicinales específicos para niños, lactantes o prenatales.
ARP130100945A 2012-03-23 2013-03-22 Material no-viable derivado de probioticos apto para la prevencion y tratamiento de infeccion, composicion AR090473A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12161083 2012-03-23

Publications (1)

Publication Number Publication Date
AR090473A1 true AR090473A1 (es) 2014-11-12

Family

ID=48045112

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100945A AR090473A1 (es) 2012-03-23 2013-03-22 Material no-viable derivado de probioticos apto para la prevencion y tratamiento de infeccion, composicion

Country Status (18)

Country Link
US (2) US20130251829A1 (es)
EP (1) EP2827725A1 (es)
CN (2) CN108714157A (es)
AR (1) AR090473A1 (es)
AU (1) AU2013235365B2 (es)
CA (1) CA2868109A1 (es)
CO (1) CO7151477A2 (es)
EC (1) ECSP14024082A (es)
HK (1) HK1204869A1 (es)
MX (1) MX360591B (es)
MY (1) MY169754A (es)
NZ (1) NZ627915A (es)
PE (1) PE20142276A1 (es)
PH (1) PH12014502112A1 (es)
RU (1) RU2014137188A (es)
SG (1) SG11201404378XA (es)
TW (1) TWI587864B (es)
WO (1) WO2013142403A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US20150157048A1 (en) 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
US20150290261A1 (en) * 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US20150305385A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20160029682A1 (en) 2014-08-01 2016-02-04 Mead Johnson Nutrition Company Hydrolyzed lactose-containing nutritional compositions and uses thereof
US20160095339A1 (en) 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US20180064739A1 (en) 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161381A1 (en) * 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions and methods for reducing the occurrence or severity of viral infections, bacterial infections and viral and bacterial co-infections
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US20180333426A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
CN107812018A (zh) * 2017-11-13 2018-03-20 浙江禾健生营养食品有限公司 一种灭活益生菌制品、制备方法及其应用
US20190208807A1 (en) * 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
GB2573538B (en) 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
WO2024124272A1 (en) * 2022-12-14 2024-06-20 BiomeMega Pty Ltd Compositions containing probiotic supernatants

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
EP1787532A3 (en) 1991-01-24 2010-03-31 Martek Biosciences Corporation Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
CN1164186C (zh) * 2001-04-29 2004-09-01 上海光明乳业股份有限公司 益菌奶及其制造方法
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
US7407652B2 (en) * 2005-06-03 2008-08-05 Aquatechnics Inc. Probiotic system for aquaculture
WO2007057872A2 (en) * 2005-11-21 2007-05-24 Teagasc-National Diary Products Research Centre Casein-derived antimicrobial peptides and lactobacillus strains that produce them
MX2009008875A (es) * 2007-02-28 2009-08-28 Mead Johnson Nutrition Co Producto que contiene probiotico inactivado para niños o infantes.
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
RU2350648C1 (ru) * 2007-09-14 2009-03-27 Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук Способ оценки антагонистической активности пробиотиков на основе лиофилизированной биомассы анаэробных бактерий по отношению к патогенным микобактериям
EP2130440A1 (en) 2008-06-06 2009-12-09 N.V. Nutricia Inhibiting E. sakazakii growth
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
CN104531562B (zh) * 2014-12-09 2018-09-14 北京农学院 一种植物乳杆菌植物亚种及其抗单增李斯特菌细菌素的制备方法

Also Published As

Publication number Publication date
CO7151477A2 (es) 2014-12-29
US20130251829A1 (en) 2013-09-26
PE20142276A1 (es) 2015-01-23
TW201400124A (zh) 2014-01-01
PH12014502112A1 (en) 2014-12-10
AU2013235365B2 (en) 2016-05-19
CA2868109A1 (en) 2013-09-26
MY169754A (en) 2019-05-15
MX360591B (es) 2018-11-09
CN108714157A (zh) 2018-10-30
ECSP14024082A (es) 2015-09-30
EP2827725A1 (en) 2015-01-28
NZ627915A (en) 2016-07-29
SG11201404378XA (en) 2014-08-28
TWI587864B (zh) 2017-06-21
MX2014010150A (es) 2014-09-16
WO2013142403A1 (en) 2013-09-26
HK1204869A1 (en) 2015-12-11
RU2014137188A (ru) 2016-05-20
CN104219968A (zh) 2014-12-17
US20170157185A1 (en) 2017-06-08
AU2013235365A1 (en) 2014-08-21

Similar Documents

Publication Publication Date Title
AR090473A1 (es) Material no-viable derivado de probioticos apto para la prevencion y tratamiento de infeccion, composicion
ECSP12011786A (es) Material inviable derivado de probióticos para la prevención y el tratamiento de alergias
CL2019002640A1 (es) Moléculas propioticas para reducir virulencia de patógenos.
ECSP15019323A (es) Derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina que contienen un grupo sulfoximina
MY169373A (en) Process for obtaining citrus fiber from citrus peel
MX2015016076A (es) Compuesto de colorante derivados de genipina o materiales que contienen genipina.
UA109575C2 (uk) Спосіб термічної стерилізації медичного контейнера
BR112013010881A2 (pt) preparações de bebida de iogurte contendo micro-organismos probióticos não replicantes
MY174631A (en) Softening compositions including fermented fruit solutions and methods for making and using the same
AR106578A1 (es) Composiciones nutricionales para la promoción de la función de barrera intestinal y alivio del dolor visceral
TW201611886A (en) Kit for removing bacterial endotoxin in biological product, method thereof, and preparation method of biological product
AR109212A1 (es) Composición que comprende etoxilato de alcohol y glucamida
WO2015031414A3 (en) Method of performing sterilization cycle
EA201691563A1 (ru) Сухой кислотный концентрат в гранулированной форме
EA201400216A1 (ru) Консервирование биологических продуктов, в частности вакцин, с применением вакуума
AR084533A1 (es) Bebidas con ingredientes lacteos con sabores mejorados y metodo de elaboracion de las mismas
EA201691608A1 (ru) Композиция смолы и формованное изделие в виде листа из нее
MX2016001460A (es) Dispositivo de extraccion de jugo para productos agricolas como frutos citricos y similares.
Keshavarzian et al. The incidence of congenital hypothyroidism and its determinants from 2012 to 2014 in Shadegan, Iran
TH187611B (th) เครื่องอบฆ่าเชื้อ
MX2015012730A (es) Composicion prebiotica y metodo de uso.
EA201070573A1 (ru) Фруктовый приготовленный продукт
CN302270259S (zh) 离心瓶
RU2012119414A (ru) Биологически активная чистая структурированная вода растительного происхождения с натуральным ароматом
TH154437S (th) ที่ใส่ภาชนะสำหรับรถเข็นเตียงผู้ป่วย

Legal Events

Date Code Title Description
FB Suspension of granting procedure